Given the proportion of CHIP-associated diseases and diversity of mutations that drive CHIP, a key focus of the field has been understanding both intrinsic advantages of HSPCs harboring CHIP mutations and extrinsic BM niche changes with age, environmental exposures, infection, and other lifestyle factors that facilitate mutant HSPC competitiveness and expansion (15). Here, STUB1 is linked to infection.